Wet AMD Treatment Options: Injections, Photodynamic Therapy, and Costs

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

Macular degeneration affecting the wet form progresses differently than the dry type, often requiring prompt medical attention to preserve vision. Wet AMD develops when abnormal blood vessels grow beneath the retina, leaking fluid or blood that distorts central vision. This process is driven largely by a protein called vascular endothelial growth factor, or VEGF, which stimulates the growth of these fragile vessels.

What Causes VEGF Activity in Wet AMD

VEGF is a naturally occurring protein that helps the body form new blood vessels, but in wet AMD, excessive VEGF production leads to abnormal vessel growth under the retina. These vessels are prone to leaking fluid and blood, causing swelling and scarring that can distort or damage central vision. Because this process can progress rapidly, early diagnosis and treatment are considered important for limiting vision loss. Regular eye examinations, especially for individuals over 60 or with risk factors such as smoking or family history, can help detect changes before significant damage occurs.

How Do Anti-VEGF Injections Work

Anti-VEGF injections are the primary treatment for wet AMD and work by blocking the VEGF protein, reducing abnormal blood vessel growth and leakage. Medications such as ranibizumab, aflibercept, and bevacizumab are commonly used, each administered directly into the eye by an ophthalmologist during an in-office procedure. The injection itself is typically quick, performed under local anesthetic eye drops, and many patients tolerate it well with minimal discomfort. These treatments do not cure wet AMD but can slow its progression and, in some cases, improve vision.

Understanding Treat-and-Extend Injection Schedules

Treatment schedules for anti-VEGF injections vary based on individual response, but many specialists use a treat-and-extend approach. This method involves regular injections, often monthly at first, followed by gradually longer intervals between treatments as the retina stabilizes. Long-term management is usually necessary, as stopping treatment prematurely may allow abnormal vessels to regrow. Regular monitoring through imaging techniques, such as optical coherence tomography, helps doctors adjust the schedule to each patient’s needs over time.

Comparing Wet AMD Treatment Costs and Coverage

Cost is often a significant consideration for people living with wet AMD, as treatment requires ongoing, sometimes lifelong, injections. Prices vary widely depending on the medication used, the country, and whether insurance or public health coverage applies. Bevacizumab, often used off-label, tends to be considerably less expensive than ranibizumab or aflibercept, though all three have been studied for effectiveness in treating wet AMD. Many national health systems and private insurers offer partial or full coverage, but out-of-pocket costs can still add up due to frequent visits and monitoring appointments.

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

When Is Photodynamic Therapy Recommended

Photodynamic therapy, or PDT, is an older treatment approach that uses a light-activated drug called verteporfin to target abnormal blood vessels while minimizing damage to surrounding tissue. Once a primary treatment for wet AMD, PDT is now used less frequently, typically reserved for specific cases where anti-VEGF injections alone are insufficient or when certain types of abnormal vessels are present. Doctors often base treatment decisions on factors such as the location and size of the abnormal vessels, overall eye health, and how the patient has responded to previous therapies. In some cases, PDT is combined with anti-VEGF injections for a more comprehensive approach.

Managing wet AMD generally involves an ongoing partnership between patient and eye care specialist, with treatment plans adjusted based on how the condition responds over time. While anti-VEGF injections remain the primary treatment method for most patients, photodynamic therapy continues to play a role in select cases. Understanding the available options, associated costs, and the importance of consistent follow-up care can help patients navigate their treatment journey with greater confidence.